Advisory Board and Editors Oncology
Jian Song
Since 2016 Dr. Jian Song has been Priv.-Doz of Experimental Immunology within the Institute of Physiological Chemistry and Pathobiochemsitry at the University of Münster, Germany. He received his PhD of Molecular Medicine from Cologne University, Germany.
Dr. Song's research interests include investigating the role of basement membranes and matrix metalloproteinases in leukocyte extravasation into the brain and into the tumour microenvironment using intravital imaging and scRNA technology
Mitchell S Stark
For the past 20 years I have been actively working in the field of melanoma and naevi genomics. I have worked and performed my PhD candidature based at the QIMR Berghofer Medical Research Institute (1999-2015) and in 2015 I relocated as a Research Fellow in the Dermatology Research Centre, The University of Queensland Diamantina Institute. Over this time I have been working towards understanding the aetiology of melanoma, studying gene dysregulation during tumour progression along with predisposition to melanoma in families with high risk for melanoma development. My research group (genomics and miRNA biomarker discovery) based within the Dermatology Research Centre (UQDI) is currently engaged in miRNA biomarker and genomics research for early detection in melanoma, skin cancer (SCC), as well as non-small cell lung cancer.
Lesley A Stark
Lesley Stark received a B.Sc (1st) from the University of Aberdeen (1990). She carried out her PhD with C. Bird at the University of Edinburgh and her first postdoc with RT Hay at the University of St Andrews. She moved back to the University of Edinburgh in 1997 to the lab of MG Dunlop. In 2002 was awarded a CRF fellowship to investigate NF-kB and aspirin chemoprevention. She was appointed as a lecturer/PI at the University of Edinburgh in 2005, a senior lecturer in 2008 then a reader in 2012.
Eike Staub
TU Braunschweig & Uni Glasgow. Metagen Gesellschaft für Genomforschung mbH.
Max Planck Institute for Molecular Genetics. Altana Pharma AG. And currently Merck Healthcare KGaA
My speciality areas are Computational Biology, Systems Biology, Oncogenomics, Drug Target Identification, Biomarker Research.
Maria Patrizia Stoppelli
Maria Patrizia Stoppelli is currently Research Director at Institute of Genetics and Biophysics, National Research Council, Naples (Italy). She has worked in prestigious Institutions like the NIH-NCI, Bethesda, Md and the MIT, Cambridge, MA and developed an internationally recognised research profile in tumour cell migration and invasion with over 65 publications and 2 patents to her name. In 2014, Dr Stoppelli qualified as Full professor in General and Clinical Biochemistry.
Anne Marie Strohecker
Assistant Professor Departments of Cancer Biology and Genetics and Surgery, The Ohio State University
We are interested in mechanisms of autophagy regulation, with a focus on discovering how to modulate the pathway for optimal therapeutic benefit. Current projects are focused on the identification of novel autophagy regulators and their functional relevance for lung tumorigenesis
Nicholas Syn
Nicholas Syn, MBBS, is a researcher at Yong Loo Lin School of Medicine, National University of Singapore. His research interests are in general surgery, transplant surgery, and translational oncology. He has published over 109 PubMed-indexed articles in these areas, and has a H-index of 19 (updated as of 16th Apr, 2021).
Gyorgy Szabadkai
Senior Lecturer, Department of Cell & Developmental Biology, University College London. Co-Founder of the Consortium for Mitochondrial Research at UCL.
Kazuki Takakura
Dr. Jonas Frederikson is an orthopedic surgeon who believes that patient care should be a physician's first priority. He specializes in laparoscopic procedures that minimize pain and recovery time, and has expertise in minimally invasive total knee replacement surgeries. Awarded the Distinguished Service Award from the American Medical Association in 2017, Dr. Frederikson has been published in both the Journal of the American Podiatric Medical Association and the New England Journal of Medicine. He holds a medical degree from the Medical University of South Carolina, where he completed a postdoctoral fellowship in the field of orthopedic medicine.
Jeffrey A. Toretsky
Professor of Pediatrics and Oncology at Georgetown Universitys Lombardi Comprehensive Cancer Center in Washington, DC. Leads the Molecular Oncology Program. Board certified in Pediatric Hematology/Oncology. Received the Burroughs-Wellcome Clinical Scientist Award in Translational Research in 2008.
Abhishek Tyagi
I have been working on the molecular mechanisms of cancer progression and metastasis for the last ten years, identifying signaling pathways that promote cancer progression using various in vitro and in vivo models. During this time, I have published 30 articles with more than 2000 citations, and 12 papers have been cited as being in the top 10% of the field. They have mostly appeared in high-impact journals such as Sci. Adv., Nat. Comm., J. Exp. Med., Clinical Can. Res., Oncogene, Cancer Res., Cancer Letters. My research is primarily concerned with mechanistic and translational studies of tumor-initiating cells, the microenvironment, and non-coding RNAs in the context of cancer progression and metastasis. My long-term research goal is to conduct basic and translational research to elucidate the underlying mechanism(s) driving cancer metastasis and identify therapeutic targets, especially for highly aggressive metastatic cancers. In addition, I also serve on the editorial boards of three cancer-related journals. Before joining the department of Cancer Biology at Wake Forest University School of Medicine, I was a senior research officer (SRO) at the Delhi State Cancer Institute, India (Govt. of India).
I am or have been...
1. A self-motivated, goal-oriented cellular/molecular biologist with over 7 years of experience in oncology.
2. Substantial experience in designing and executing well-controlled in vitro and in vivo assays for preclinical drug discovery, synthetic lethal screening, biomarker identification, target validation, immunogenicity, and toxicity assessment
3. Capable of investigating signaling pathways with a variety of molecular and genetic tools
4. Enthusiastic team worker and expert in forming strategic collaborations
Alfonso Valencia
Bioinformatician. Interested in biological networks, cancer biology, text mining, and personalised medicine.
ICREA professor. Director of the Life Sciences Department at Barcelona Supercomputing Center. Director of the Spanish Bioinformatics Institute (INB / ELIXIR-ES) and Executive Editor of Bioinformatics. Elected Fellow and President of the International Society for Comptuational Biology (ISCB). Member of EMBO.